The following table presents the impact and location of the amounts reclassified from AOCL into net earnings on the Condensed Consolidated Statements of Earnings and the impact of derivative instruments on the Condensed Consolidated Statements of Comprehensive Income for the company's derivatives designated as cash flow hedging instruments for the three and nine months ended July 31, 2026 and August 1, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | | Gain (Loss) Reclassified from AOCL into Earnings | | Gain (Loss) Recognized in OCI on Derivatives | | (Dollars in millions) | | July 31, 2026 | | August 1, 2025 | | July 31, 2026 | | August 1, 2025 | | Derivatives designated as cash flow hedging instruments: | | | | | | | | | | Forward currency contracts: | | | | | | | | | | Net sales | | $ | (1.8) | | | $ | (1.3) | | | $ | 6.1 | | | $ | 0.4 | | | Cost of sales | | 0.6 | | | (0.9) | | | (0.2) | | | 3.1 | | | Total derivatives designated as cash flow hedging instruments | | $ | (1.2) | | | $ | (2.2) | | | $ | 5.9 | | | $ | 3.5 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nine Months Ended | | | Gain (Loss) Reclassified from AOCL into Earnings | | Gain (Loss) Recognized in OCI on Derivatives | | (Dollars in millions) | | July 31, 2026 | | August 1, 2025 | | July 31, 2026 | | August 1, 2025 | | Derivatives designated as cash flow hedging instruments: | | | | | | | | | | Forward currency contracts: | | | | | | | | | | Net sales | | $ | (7.2) | | | $ | 0.2 | | | $ | 2.6 | | | $ | (4.8) | | | Cost of sales | | 1.1 | | | (4.1) | | | 2.9 | | | 7.4 | | | Total derivatives designated as cash flow hedging instruments | | $ | (6.1) | | | $ | (3.9) | | | $ | 5.5 | | | $ | 2.6 | |
The following tables present the impact and location of derivative instruments on the Condensed Consolidated Statements of Earnings for the company’s derivatives designated as cash flow hedging instruments and the related components excluded from effectiveness testing: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (Loss) Gain Recognized in Earnings on Cash Flow Hedging Instruments | | (Dollars in millions) | | July 31, 2026 | | August 1, 2025 | | Three Months Ended | | Net Sales | | Cost of Sales | | Net Sales | | Cost of Sales | | Condensed Consolidated Statements of Earnings (Loss) income (expense) amounts in which the effects of cash flow hedging instruments are recorded | | $ | 1,225.8 | | | $ | (807.7) | | | $ | 1,131.3 | | | $ | (749.5) | | | (Loss) gain on derivatives designated as cash flow hedging instruments: | | | | | | | | | | Forward currency contracts: | | | | | | | | | | Amount of (loss) gain reclassified from AOCL into earnings | | (1.8) | | | 0.6 | | | (1.3) | | | (0.9) | | | (Loss) gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value | | $ | (1.0) | | | $ | 0.8 | | | $ | 0.1 | | | $ | 1.0 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | (Loss) Gain Recognized in Earnings on Cash Flow Hedging Instruments | | (Dollars in millions) | | July 31, 2026 | | August 1, 2025 | | Nine Months Ended | | Net Sales | | Cost of Sales | | Net Sales | | Cost of Sales | | Condensed Consolidated Statements of Earnings income (expense) amounts in which the effects of cash flow hedging instruments are recorded | | $ | 3,686.8 | | | $ | (2,449.5) | | | $ | 3,444.2 | | | $ | (2,290.1) | | | (Loss) gain on derivatives designated as cash flow hedging instruments: | | | | | | | | | | Forward currency contracts: | | | | | | | | | | Amount of (loss) gain reclassified from AOCL into earnings | | (7.2) | | | 1.1 | | | 0.2 | | | (4.1) | | | Gain on components excluded from effectiveness testing recognized in earnings based on changes in fair value | | $ | 1.5 | | | $ | 1.9 | | | $ | 0.8 | | | $ | 2.6 | |
|